BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11241210)

  • 1. Modulation of membrane curvature by peptides.
    Epand RM; Epand RF
    Biopolymers; 2000; 55(5):358-63. PubMed ID: 11241210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide models for the membrane destabilizing actions of viral fusion proteins.
    Epand RM; Cheetham JJ; Epand RF; Yeagle PL; Richardson CD; Rockwell A; Degrado WF
    Biopolymers; 1992 Apr; 32(4):309-14. PubMed ID: 1623124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors contributing to the fusogenic potency of foamy virus.
    Epand RM; Epand RF
    Biochem Biophys Res Commun; 2001 Jun; 284(4):870-4. PubMed ID: 11409874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanisms of lipid-protein rearrangements during viral infection.
    Chizmadzhev YA
    Bioelectrochemistry; 2004 Jun; 63(1-2):129-36. PubMed ID: 15110263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of single chain lipids on phospholipase C-promoted vesicle fusion. A test for the stalk hypothesis of membrane fusion.
    Basáñez G; Goñi FM; Alonso A
    Biochemistry; 1998 Mar; 37(11):3901-8. PubMed ID: 9521711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
    Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aromatic domain of the coronavirus class I viral fusion protein induces membrane permeabilization: putative role during viral entry.
    Sainz B; Rausch JM; Gallaher WR; Garry RF; Wimley WC
    Biochemistry; 2005 Jan; 44(3):947-58. PubMed ID: 15654751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of various small-molecule anesthetics on vesicle fusion: a study using two-photon fluorescence cross-correlation spectroscopy.
    Nguyen TT; Swift JL; Burger MC; Cramb DT
    J Phys Chem B; 2009 Jul; 113(30):10357-66. PubMed ID: 19580302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the spontaneous curvature and bending rigidity of lipid membranes by interfacially adsorbed amphipathic peptides.
    Zemel A; Ben-Shaul A; May S
    J Phys Chem B; 2008 Jun; 112(23):6988-96. PubMed ID: 18479112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion peptide-phospholipid noncovalent interactions as observed by nanoelectrospray FTICR-MS.
    Li Y; Heitz F; Le Grimellec C; Cole RB
    Anal Chem; 2005 Mar; 77(6):1556-65. PubMed ID: 15762557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different activities of the reovirus FAST proteins and influenza hemagglutinin in cell-cell fusion assays and in response to membrane curvature agents.
    Clancy EK; Barry C; Ciechonska M; Duncan R
    Virology; 2010 Feb; 397(1):119-29. PubMed ID: 19931884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research advances on fusion peptide and mechanisms about virus penetration into membrane].
    Wu M; Nie SQ
    Sheng Li Ke Xue Jin Zhan; 1998 Jul; 29(3):221-5. PubMed ID: 12501639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of curvature and hydrophobic interstice energy in fusion: studies of lipid perturbant effects.
    Haque ME; Lentz BR
    Biochemistry; 2004 Mar; 43(12):3507-17. PubMed ID: 15035621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion peptides and transmembrane domains of fusion proteins are characterized by different but specific structural properties.
    Weise K; Reed J
    Chembiochem; 2008 Apr; 9(6):934-43. PubMed ID: 18330852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexapeptides that interfere with HIV-1 fusion peptide activity in liposomes block GP41-mediated membrane fusion.
    Gómara MJ; Lorizate M; Huarte N; Mingarro I; Perez-Payá E; Nieva JL
    FEBS Lett; 2006 May; 580(11):2561-6. PubMed ID: 16647705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanidination of notexin promotes its phospholipase A(2) activity-independent fusogenicity on vesicles with lipid-supplied negative curvature.
    Kao PH; Chiou YL; Chen YJ; Lin SR; Chang LS
    Toxicon; 2012 Jan; 59(1):47-58. PubMed ID: 22030836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying critical components of native Ca2+-triggered membrane fusion. Integrating studies of proteins and lipids.
    Furber KL; Churchward MA; Rogasevskaia TP; Coorssen JR
    Ann N Y Acad Sci; 2009 Jan; 1152():121-34. PubMed ID: 19161383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Mechanism of Viral Peptide-Induced Membrane Fusion.
    Pattnaik GP; Meher G; Chakraborty H
    Adv Exp Med Biol; 2018; 1112():69-78. PubMed ID: 30637691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral fusion peptides and identification of membrane-interacting segments.
    Del Angel VD; Dupuis F; Mornon JP; Callebaut I
    Biochem Biophys Res Commun; 2002 May; 293(4):1153-60. PubMed ID: 12054496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion pore stability of peptidergic vesicles.
    Jorgacevski J; Fosnaric M; Vardjan N; Stenovec M; Potokar M; Kreft M; Kralj-Iglic V; Iglic A; Zorec R
    Mol Membr Biol; 2010 Apr; 27(2-3):65-80. PubMed ID: 20334578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.